Showing 1 - 3 results of 3 for search 'Shida Pan', query time: 0.02s Refine Results
  1. 1
    Early Alpha-Fetoprotein Response Predicts Sustained Tumor Response Following Immune Checkpoint Inhibitors Combined with Targeted Therapy in Liver Cancer

    Early Alpha-Fetoprotein Response Predicts Sustained Tumor Response Following Immune Checkpoint Inhibitors Combined with Targeted Therapy in Liver Cancer by Jiahe Tian, Shida Pan, Yilin Wang, Yingying Yu, Siyu Wang, Yingjuan Shen, Luo Yang, Xiaomeng Liu, Qin Qiu, Junqing Luan, Fusheng Wang, Fanping Meng

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinemia: a retrospective cohort study

    Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinemia: a re... by Shida Pan, Shida Pan, Jianing Wang, Jianing Wang, Jiahe Tian, Jiahe Tian, Yilin Wang, Yilin Wang, Siyu Wang, Yingying Yu, Yingying Yu, Fengyi Li, Yan-Mei Jiao, Yingjuan Shen, Luo Yang, Xiaomeng Liu, Qin Qiu, Junqing Luan, Fu-Sheng Wang, Fu-Sheng Wang, Fu-Sheng Wang, Fu-Sheng Wang, Fanping Meng, Fanping Meng, Fanping Meng

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study

    Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study by Yilin Wang, Shida Pan, Jiahe Tian, Jianing Wang, Yingying Yu, Siyu Wang, Fengyi Li, Luo Yang, Xiaomeng Liu, Yingjuan Shen, Qin Qiu, Junqing Luan, Mengdie Jia, Chuyue Xiong, Xuanxuan Duan, Fu-Sheng Wang, Fanping Meng

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: